Related Experiment Video
Updated: Jun 26, 2026
09:04
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
NALP3 inflammasome functional polymorphisms and gout susceptibility
Zhi-Min Miao1, Shi-Hua Zhao, Sheng-Li Yan
1Department of Medicine, the Affiliated Hospital of Qingdao Medical College, Qingdao University, Qingdao, P.R. China. miaozm@qdumh.qd.sd.cn
Cell Cycle (Georgetown, Tex.)
|December 25, 2008
Summary
Genetic mutations in the NALP3 inflammasome may predispose individuals to gout, a common autoinflammatory arthritis. Further research is needed to confirm the NALP3 inflammasome
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Gout is a prevalent autoinflammatory arthritis linked to elevated serum urate and monosodium urate (MSU) crystal deposition.
- While genetic factors influencing urate metabolism are known, they don't fully explain why only a fraction of hyperuricemia patients develop gout.
- The NALP3 inflammasome, an innate immune complex, is implicated in MSU crystal-induced inflammation, a key aspect of gout pathogenesis.
Purpose of the Study:
- To propose a novel hypothesis linking functional mutations in the NALP3 inflammasome to gout susceptibility.
- To identify the NALP3 inflammasome as a potential genetic marker for gout.
- To highlight the need for further clinical genetic studies to validate this hypothesis.
Main Methods:
- Review of existing literature on gout pathogenesis, genetic factors, and inflammasome involvement.
- Analysis of recent studies on NALP3 and CARD-8 mutations in autoinflammatory diseases.
- Formulation of a hypothesis based on accumulated genetic evidence.
Main Results:
- Accumulated evidence suggests that genes unrelated to urate metabolism may contribute to gout susceptibility.
- The NALP3 inflammasome is involved in the innate immune response to MSU crystals.
- Functional mutations in NALP3 and CARD-8 are associated with other autoinflammatory conditions.
Conclusions:
- The NALP3 inflammasome is a compelling candidate for gout susceptibility and a potential genetic marker.
- Functional mutations in the NALP3 inflammasome may play a significant role in the etiology of gout.
- Clinical genetic studies are essential to confirm the involvement of the NALP3 inflammasome in gout development.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...